COMBINATION MCL-1 INHIBITORS WITH ANTI-BODY DRUG CONJUGATES
The present disclosure generally relates to methods of treating cancer by administering an MCL-1 inhibitor and an antibody-drug conjugate. La présente divulgation concerne de manière générale des méthodes de traitement du cancer par administration d'un inhibiteur de MCL-1 et d'un conjugué...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | MATSON, CLINTON K VENKATARAMANI, CHANDRASEKAR KENNEY, THOMAS F |
| description | The present disclosure generally relates to methods of treating cancer by administering an MCL-1 inhibitor and an antibody-drug conjugate.
La présente divulgation concerne de manière générale des méthodes de traitement du cancer par administration d'un inhibiteur de MCL-1 et d'un conjugué anticorps-médicament. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA3222752A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA3222752A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA3222752A13</originalsourceid><addsrcrecordid>eNrjZLB29vd18vRzDPH091PwdfbRNVTw9PPwdPIM8Q8KVgj3DPFQcPQL8dR18neJVHAJCnVXcPb38wp1dwxxDeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjsZGRkbmpkaOhsZEKAEAfIoopg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMBINATION MCL-1 INHIBITORS WITH ANTI-BODY DRUG CONJUGATES</title><source>esp@cenet</source><creator>MATSON, CLINTON K ; VENKATARAMANI, CHANDRASEKAR ; KENNEY, THOMAS F</creator><creatorcontrib>MATSON, CLINTON K ; VENKATARAMANI, CHANDRASEKAR ; KENNEY, THOMAS F</creatorcontrib><description>The present disclosure generally relates to methods of treating cancer by administering an MCL-1 inhibitor and an antibody-drug conjugate.
La présente divulgation concerne de manière générale des méthodes de traitement du cancer par administration d'un inhibiteur de MCL-1 et d'un conjugué anticorps-médicament.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221215&DB=EPODOC&CC=CA&NR=3222752A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221215&DB=EPODOC&CC=CA&NR=3222752A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MATSON, CLINTON K</creatorcontrib><creatorcontrib>VENKATARAMANI, CHANDRASEKAR</creatorcontrib><creatorcontrib>KENNEY, THOMAS F</creatorcontrib><title>COMBINATION MCL-1 INHIBITORS WITH ANTI-BODY DRUG CONJUGATES</title><description>The present disclosure generally relates to methods of treating cancer by administering an MCL-1 inhibitor and an antibody-drug conjugate.
La présente divulgation concerne de manière générale des méthodes de traitement du cancer par administration d'un inhibiteur de MCL-1 et d'un conjugué anticorps-médicament.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB29vd18vRzDPH091PwdfbRNVTw9PPwdPIM8Q8KVgj3DPFQcPQL8dR18neJVHAJCnVXcPb38wp1dwxxDeZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjsZGRkbmpkaOhsZEKAEAfIoopg</recordid><startdate>20221215</startdate><enddate>20221215</enddate><creator>MATSON, CLINTON K</creator><creator>VENKATARAMANI, CHANDRASEKAR</creator><creator>KENNEY, THOMAS F</creator><scope>EVB</scope></search><sort><creationdate>20221215</creationdate><title>COMBINATION MCL-1 INHIBITORS WITH ANTI-BODY DRUG CONJUGATES</title><author>MATSON, CLINTON K ; VENKATARAMANI, CHANDRASEKAR ; KENNEY, THOMAS F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA3222752A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MATSON, CLINTON K</creatorcontrib><creatorcontrib>VENKATARAMANI, CHANDRASEKAR</creatorcontrib><creatorcontrib>KENNEY, THOMAS F</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MATSON, CLINTON K</au><au>VENKATARAMANI, CHANDRASEKAR</au><au>KENNEY, THOMAS F</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMBINATION MCL-1 INHIBITORS WITH ANTI-BODY DRUG CONJUGATES</title><date>2022-12-15</date><risdate>2022</risdate><abstract>The present disclosure generally relates to methods of treating cancer by administering an MCL-1 inhibitor and an antibody-drug conjugate.
La présente divulgation concerne de manière générale des méthodes de traitement du cancer par administration d'un inhibiteur de MCL-1 et d'un conjugué anticorps-médicament.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_CA3222752A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMBINATION MCL-1 INHIBITORS WITH ANTI-BODY DRUG CONJUGATES |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T20%3A59%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MATSON,%20CLINTON%20K&rft.date=2022-12-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA3222752A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |